Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy the ...

Portable genome sequencers are revolutionizing genomic research. However, their reliance on external systems introduces new vulnerabilities that threaten the security of these sequencers. By employing ...

Data and Operations professionals are increasingly tasked with reducing operational risk while increasing efficiency. Yet officers and managers are asked to do more with less — such as pursuing new ...

Vistra to buy Cogentrix Energy in $4.7 billion deal amid surging power demand Utility Vistra said on Monday it has agreed to buy Cogentrix Energy, comprising 10 natural gas-fired power plants, from ...